Journals / Acta Orthopaedica et Traumatologica Turcica / 2014 / Cilt: 48 - Sayı: 2

Topikal gliseril trinitrat ile tenisçi dirseğinin tedavisi

Management of tennis elbow with topical glyceryl trinitrate

Pages
175–180
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The administration of NO directly over an area of tendinopathy through a GTN patch reduces pain and other symptoms in chronic LE.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the treatment results of the application of nitric oxide (NO) in the form of topical glyceryl trinitrate (GTN) for the treatment of lateral epicondylitis (LE).
📊
Key Findings & Data:Methods: The study included 40 patients with LE randomized into 2 equal groups.
💡
Conclusion & Impact:Conclusion: The administration of NO directly over an area of tendinopathy through a GTN patch reduces pain and other symptoms in chronic LE.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the treatment results of the application of nitric oxide (NO) in the form of topical glyceryl trinitrate (GTN) for the treatment of lateral epicondylitis (LE). Methods: The study included 40 patients with LE randomized into 2 equal groups. Selection criteria included the presence of pain, tenderness, and positive pain stimulating maneuvers. Glyceryl trinitrate patches were applied to the area of maximal tenderness once a day in the treatment group and placebo patches in the control group. Outcomes in terms of pain relief was assessed using the visual analog scale (VAS) and were evaluated according to the criteria of Verhaar et al. Excellent or good results were considered successful. Differences in VAS scores between the two groups were calculated using the Mann-Whitney U-test and the chi-square test was used to investigate distributions of categorical variables (sex, affected side) and good and excellent results among groups. Results: There were no significant differences in any of the baseline clinical parameters between groups. At the 3rd week follow-up, there were statistically significant differences in the pain measured using VAS between groups (mean VAS score of the control and treatment groups were 6.45 and 3.15, respectively) (p=0.001). Patients in the GTN group and control group had lower VAS pain scores and reduced elbow pain at 3 weeks (3.15 vs 8.05 in the GTN and 6.45 vs 8.80 in the control group). In the control group, no patient had excellent or good results while 18 (90%) patients in treatment group reported successful treatment. There was statistically significant difference in the VAS measured at 6 months between groups (mean VAS score of the control and treatment groups were 4.85 and 0.70, respectively) (p=0.001). Conclusion: The administration of NO directly over an area of tendinopathy through a GTN patch reduces pain and other symptoms in chronic LE.

Özet

Amaç: Bu çalışmada, lateral epikondilitin (LE) tedavisinde topikal gliseril trinitrat (GTN) formunda nitrik oksit (NO) uygulaması ile tedavi edilen hastaların tedavi sonuçlarının değerlendirilmesi amaçlanmıştır. Çalışma planı: Lateral epikondiliti olan 40 hasta rastgele 2 eşit gruba bölündü. Seçim kriterleri ağrı, hassasiyet ve ağrı uyarıcı manevraların pozitifliği olarak kabul edildi. Teadvi grubunda GTN yamaları, kontrol grubunda ise plasebo yamalar günde bir kez olmak üzere en çok hassasiyet olan bölgeye uygulandı. Hastaların görsel analog skala (GAS) ile ağrının ne derece giderildiği bazında değerlendirildi ve sonuçlar Verhaar ve ark.’nın kriterlerine göre sınıflandırıldı. Mükemmel ve iyi sonuçlar başarılı tedavi olarak kabul edildi. Gruplar arası GAS skorundaki farklılık Mann-Whitney U-testi ile hesaplandı. Kategorik değişkenlerin dağılımları (cinsiyet, etkilenen taraf) ve gruplar arası iyi ve mükemmel sonuçların karşılaştırılması için ki-kare testi kullanıldı. Bulgular: Tedavi başlangıcında, iki grup arasında klinik parametreler açısından istatistiksel olarak anlamlı bir fark yoktu. Hastaların 3. hafta sonundaki GAS değerlendirmesinde iki grup arasında istatiksel olarak anlamlı ölçüde fark bulundu (kontrol ve tedavi gruplarının ortalama GAS skorları, sırasıyla, 6.45 ve 3.15 idi) (p=0.001). Gliseril trinitrat uygulanan hastalar ve kontrol grubundaki hastalarda 3. hafta sonunda anlamlı derecede düşük GAS skoru (GTN grubunda GAS skoru başlangıç değeri 8.05’ten 3.15’e, kontrol grubunda ise başlangıç değeri 8.80’den 6.45’e gerilemişti) ve azalmış dirsek ağrısı saptandı. Kontrol grubunda hiç mükemmel ve iyi sonuç olmamasına rağmen, tedavi grubunda 18 hastada (%90) başarı kaydedildi. Altıncı ay sonunda grupların GAS skorları arasında istatistiksel olarak anlamlı ölçüde fark belirlendi (kontrol ve tedavi gruplarının ortalama GAS skorları, sırasıyla, 4.85 ve 0.70 idi) (p=0.001). Çıkarımlar: Gliseril trinitrat yaması kullanılarak tendinopatili bölge üzerine uygulanan NO, kronik LE’deki ağrı ve diğer semptomları azaltmaktadır.

🔖

Cite This Article

ÖDEN, R., URUÇ, V., DOĞRAMACI, Y., KALACI, A., YENGİL, E. (2014). Topikal gliseril trinitrat ile tenisçi dirseğinin tedavisi. Acta Orthopaedica et Traumatologica Turcica, Cilt: 48 - Sayı: 2, 175–180. https://ajindex.com/articles/353668

References (14)

  1. De Smedt T, de Jong A, Van Leemput W, Lieven D, Van Glabbeek F. Lateral epicondylitis in tennis: update on aetiology, biomechanics and treatment. Br J Sports Med 2007
  2. CrossRef 2. Rayan F, Rao V Sr, Purushothamdas S, Mukundan C, Shafqat SO. Common extensor origin release in recalci- trant lateral epicondylitis - role justified? J Orthop Surg Res 2010
  3. CrossRef 3. Haahr JP, Andersen JH. Physical and psychosocial risk factors for lateral epicondylitis: a population based case- referent study. Occup Environ Med 2003
  4. CrossRef 4. Faro F, Wolf JM. Lateral epicondylitis: review and current concepts. J Hand Surg Am 2007
  5. CrossRef 5. Walz DM, Newman JS, Konin GP, Ross G. Epicondyli- tis: pathogenesis, imaging, and treatment. Radiographics 2010
  6. CrossRef 6. Van Hofwegen C, Baker CL 3rd, Baker CL Jr. Epicondyli- tis in the athlete’s elbow. Clin Sports Med 2010
  7. Murrell GA, Szabo C, Hannafin JA, Jang D, Dolan MM, Deng XH, et al. Modulation of tendon healing by nitric oxide. Inflamm Res 1997
  8. CrossRef 8. Yuan J, Murrell GA, Wei AQ, Appleyard RC, Del Soldato P, Wang MX. Addition of nitric oxide via nitroflurbipro- fen enhances the material properties of early healing of young rat Achilles tendons. Inflamm Res 2003
  9. Paoloni JA, Appleyard RC, Nelson J, Murrell GA. Topi- cal glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathy. A randomized, double-blind, place- bo-controlled trial. J Bone Joint Surg Am 2004
  10. A:916- 22. 10. Paoloni JA, Murrell GA. Three-year followup study of top- ical glyceryl trinitrate treatment of chronic noninsertional Achilles tendinopathy. Foot Ankle Int 2007
  11. McCallum SD, Paoloni JA, Murrell GA. Five-year pro- spective comparison study of topical glyceryl trinitrate treatment of chronic lateral epicondylosis at the elbow. Br J Sports Med 2011
  12. CrossRef 12. Paoloni JA, Murrell GA, Burch RM, Ang RY. Ran- domised, double-blind, placebo-controlled clinical trial of a new topical glyceryl trinitrate patch for chronic lateral epicondylosis. Br J Sports Med 2009
  13. CrossRef 13. Sanford J, Moreland J, Swanson LR, Stratford PW, Gow- land C. Reliability of the Fugl-Meyer assessment for test- ing motor performance in patients following stroke. Phys Ther 1993
  14. Svernlöv B, Adolfsson L. Non-operative treatment regime including eccentric training for lateral humeral epicon- dylalgia. Scand J Med Sci Sports 2001